Filter
1306
Text search:
pharmaceutical
policies
Featured
120
360
Language
Document type
635
294
184
83
60
15
12
11
6
3
3
Countries / Regions
62
59
54
40
37
36
32
31
27
23
22
21
20
19
19
19
17
17
16
15
14
14
13
13
12
12
11
10
10
9
9
7
7
7
7
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
580
69
63
59
31
19
11
Toolboxes
159
103
102
72
69
45
34
32
31
26
23
22
22
19
14
13
11
9
7
5
4
4
3
3
1
Guidelines for Handling Temperature Sensitive Vaccines and Pharmaceuticals
Towards ending tuberculosis and multidrug-resistant tuberculosis.
(Health Systems in Transition, Vol. 4, No. 3, 2014)
In 2017, 3.6 million of the estimated 10 million people with TB worldwide were “missed” by national TB programmes (NTPs). Two thirds of them are thought to access TB treatment of questionable quality from public and private providers who are not engaged by the NTP. The quality of care provided i
...
Progress towards targets of the Global action plan on dementia
В этом дискуссионном документе излагаются факты, касающиеся передозировки опиоидов, мер, которые могут быть приняты в целях предупреждения и лечения (коррекции) п
...
Accessed: 17.11.2019
UNAIDS 2017 / Reference
Generating evidence for policy and action on HIV and social protection
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic
...
This is the first NAP on the Prevention and Containment of AMR in Kenya. It has been developed based on the National Policy on Prevention and Containment of AMR and the recommendations of the situation analysis on AMR conducted in 2011 and updated in 2016. This strategy provides a regulatory and imp
...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
